Saccharomyces cerevisiae clinical trials
Also written Saccharomyces boulardii.
How each study uses Saccharomyces cerevisiae is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Saccharomyces cerevisiae studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
34 studies that test it; most in 2010 (4)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 4 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 29
Biocodex (3) · Lesaffre International (2) · Beth Israel Deaconess Medical Center (2) · Federal University of Minas Gerais (2) · Aga Khan University (2) · Syeda Sabeen Fatima Naqvi (1) · Seoul National University Hospital (1) · Ann & Robert H Lurie Children's Hospital of Chicago (1)
Often tested with
Tested in the same studies.
Bacillus clausii (2) · Amoxicillin (2) · Proton pump inhibitors (PPIs) (1) · Metronidazole (1) · Probiotic (1) · VPS Coriolus versicolor extract (1) · Clavulanic Acid (1) · Rifaximin (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Saccharomyces cerevisiae.
- Feb 2027Effectiveness of Saccharomyces Boulardii in Prevention of Antibiotic Associated DiarrheaNot applicable · University of Child Health Sciences and Children's Hospital, Lahore
- Feb 2027Comparison of Bacillus Clausii and Saccharomyces Boulardii for Acute Diarrhea at Day 3Not applicable · Syeda Sabeen Fatima Naqvi
Studies
Open first, then newest update. How each study uses Saccharomyces cerevisiae is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 35
- Effectiveness of Saccharomyces Boulardii in Prevention of Antibiotic Associated DiarrheaNot yet recruitingNot applicableUniversity of Child Health Sciences and Children's Hospital, LahoreNCT07785206Written as Saccharomyces boulardii
- Saccharomyces Boulardii CNCM I-745 in Irritable Bowel SyndromeRecruitingPhase 3BiocodexNCT07168434Written as Saccharomyces Boulardii 250 MG
- Efficacy Analysis of Saccharomyces Boulardii Combined With Minocycline in Treatment-naïve Patients With Helicobacter Pylori InfectionNot yet recruitingNot applicableZhongda HospitalNCT07012785Written as Saccharomyces boulardii
- Comparison of Bacillus Clausii and Saccharomyces Boulardii for Acute Diarrhea at Day 3Active, not recruitingNot applicableSyeda Sabeen Fatima NaqviNCT07853846Written as Saccharomyces boulardii
- Effect of Bioflor on Gut Microbiota in Proton-Pump Inhibitor UsersCompletedPhase 4Seoul National University HospitalNCT07852676Written as Saccharomyces Boulardii 250 MG
- A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract InfectionsCompletedEarly Phase 1Ann & Robert H Lurie Children's Hospital of ChicagoNCT06149676Written as Saccharomyces Boulardii 250 MG [Florastor]
- The Impact of Probiotic Supplementation on Antibiotic Induced Changes in Gastrointestinal Function And/or Faecal Microbiota CompositionCompletedNot applicableCultech LtdNCT05355571Written as LAB4 + Saccharomyces boulardii
- Comparison of Effectiveness of Zinc Supplementation With ORS and Bacillus Clausii Versus Zinc With ORS and Saccharomyces Boulardii in Acute Watery Diarrhea in Paediatric PatientsCompletedNot applicableRESnTEC, Institute of ResearchNCT06540209Written as Saccharomyces boulardii
- Effect of the Use of Probiotic S. Boulardii on Acute Viral Inflammatory Diarrhea Diagnosed With Multiplex PCR.CompletedNot applicableInstituto Mexicano del Seguro SocialNCT05226052Written as Saccharomyces boulardii (Floratil 600mg)
- Saccharomyces Cerevisiae for Irritable Bowel SyndromeCompletedPhase 1/2Ziauddin UniversityNCT05149599Written as Saccharomyces cerevisiae
- The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBSStatus unknownNot applicableFakultas Kedokteran Universitas IndonesiaNCT05451433Written as Saccharomyces Boulardii 250 MG
- Saccharomyces Boulardii as Pretreatment Before Rescue Therapy of Helicobacter PyloriCompletedNot applicableThe Third Xiangya Hospital of Central South UniversityNCT05191875Written as Saccharomyces Boulardii 250 MG
- Evaluation of Saccharomyces Boulardii Combined With Standard Quadruple Therapy for Eradication of Helicobacter PyloriCompletedNot applicableHuazhong University of Science and TechnologyNCT03688828Written as Saccharomyces boulardii
- Effect of 60-days Saccharomyces Boulardii and Superoxide Dismutase Supplementation in Obese AdultsCompletedNot applicableAzienda di Servizi alla Persona di PaviaNCT04919850Written as Saccharomyces boulardii and SOD
- Efficacy and Safety of Saccharomyces Boulardii in the Treatment of Small Intestinal Bacterial OvergrowthCompletedPhase 4Centro de Educación Medica e Investigaciones Clínicas Norberto QuirnoNCT04627337Written as Saccharomyces Boulardii 250 MG
- Effectiveness of Saccharomyces Boulardii for Gastrointestinal Bacterial-overgrowth in Systemic SclerosisCompletedPhase 4Coordinación de Investigación en Salud, MexicoNCT03692299Written as Saccharomyces Boulardii Oral Tablet
- Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces BoulardiiStatus unknownPhase 4Clinical Centre of SerbiaNCT03997279Written as Saccharomyces boulardii
- GutHeart: Targeting Gut Microbiota to Treat Heart FailureStatus unknownPhase 2Oslo University HospitalNCT02637167Written as Saccharomyces boulardii
- Efficacy and Safety of Probiotics in the Treatment of Acute Gastroenteritis in ChildrenCompletedPhase 4BiocodexNCT03539913Written as Probiotic : Saccharomyces boulardii
- Efficacy of Two Probiotic Preparations in Children With Acute DiarrhoeaWithdrawnNot applicableSinaloa Pediatric HospitalNCT02080130Written as Saccharomyces boulardii
See all 35 studies that test Saccharomyces cerevisiae →
Given beside what is tested · 1 — Saccharomyces cerevisiae is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with Saccharomyces cerevisiae
- A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV VaccineCompletedPhase 2Beijing Health Guard Biotechnology, IncNCT05694728Written as Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
- A Phase III Trial Evaluates the Efficacy, Immunogenicity and Safety Profile of HPV VaccineStatus unknownPhase 3Beijing Health Guard Biotechnology, IncNCT05668572Written as Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)(GARDASIL®)
Codes
What other systems call Saccharomyces cerevisiae · ClinicalTrials.gg INT015814
- UNII (FDA) 978D8U419HSACCHAROMYCES CEREVISIAEConfirmed FDA, Wikidata
- RxNorm 9511Confirmed FDA, Wikidata
- Wikidata Q719725Saccharomyces cerevisiaeConfirmed FDA, Wikidata
- NCI Thesaurus C14271Saccharomyces cerevisiaeOne source FDA
- DrugBank DB10447One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 978D8U419H | SACCHAROMYCES CEREVISIAE | Confirmed FDA, Wikidata |
| RxNorm | 9511 | — | Confirmed FDA, Wikidata |
| Wikidata | Q719725 | Saccharomyces cerevisiae | Confirmed FDA, Wikidata |
| NCI Thesaurus | C14271 | Saccharomyces cerevisiae | One source FDA |
| DrugBank | DB10447 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.